Sensient Technologies (SXT) is drawing attention after a period of solid share price performance, with the stock last closing at $101.53 and posting positive returns over the past year and past 3 months.
See our latest analysis for Sensient Technologies.
The recent 1 day share price return of 3.74%, alongside a 7 day share price return of 12.22% and a 1 year total shareholder return of 48.76%, points to momentum that has been building rather than fading.
If Sensient’s run has you looking beyond one name, this may be a good moment to broaden your search with our screener of 19 top founder-led companies.
With the shares at $101.53, revenue of $1.61b and net income of $134.49m, plus a 17% gap to the average analyst price target, you have to ask: is Sensient undervalued, or is the market already pricing in future growth?
At $101.53 against a narrative fair value of $119, Sensient Technologies is framed as trading below what long term forecasts would justify.
The imminent large-scale regulatory-driven transition from synthetic to natural colors in the U.S. (with a hard retail deadline of January 2028) presents a significant revenue inflection point for Sensient, as branded CPG customers accelerate conversions and position the company for robust top-line growth beginning in 2027.
Sensient's 15+ years of proactive investment in natural colors R&D, global manufacturing capacity, and a vertically-integrated botanical supply chain gives it a defensible advantage in meeting escalating consumer and CPG demand for clean-label, natural ingredients. This supports sustainable growth and premium pricing, which should enhance both revenue and gross margins.
Want to see what sits behind that fair value uplift? The narrative leans heavily on revenue expansion, rising margins and a future earnings multiple that assumes investors stay confident. Curious which specific targets have to line up for that price to make sense?
Result: Fair Value of $119 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on natural color demand matching expectations and agricultural costs staying manageable, because supply constraints or higher input prices could quickly pressure margins and cash flow.
Find out about the key risks to this Sensient Technologies narrative.
While the narrative fair value suggests upside, the current P/E of 32.1x sits well above the US Chemicals industry at 24x, the peer average at 30.3x, and the fair ratio of 22.2x. That premium can point to higher valuation risk, so how comfortable are you paying up for this story?
See what the numbers say about this price — find out in our valuation breakdown.
If this mix of optimism and caution has you on the fence, take a closer look now and weigh both sides by using our breakdown of 2 key rewards and 3 important warning signs.
Before you move on, give yourself a real edge by scanning a broader set of opportunities with targeted screeners that surface ideas you might otherwise miss.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com